These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 1680783)
1. [Clinical evaluation of urinary alanine aminopeptidase in the patients with diabetes mellitus-comparison among AAP microalbumin and N-acetyl-beta-D-glucosaminidase]. Nakamura S Hokkaido Igaku Zasshi; 1991 Jul; 66(4):522-33. PubMed ID: 1680783 [TBL] [Abstract][Full Text] [Related]
2. Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus. Asare-Anane H; Twum F; Kwaku Ofori E; Torgbor EL; Amanquah SD; Osafo C Dis Markers; 2016; 2016():2810639. PubMed ID: 27594733 [TBL] [Abstract][Full Text] [Related]
3. Comparison of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase activities for evaluation of microangiopathy in diabetes mellitus. Shimojo N; Kitahashi S; Naka K; Fujii A; Okuda K; Tanaka S; Fujii S Metabolism; 1987 Mar; 36(3):277-80. PubMed ID: 2881186 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. Holdt-Lehmann B; Lehmann A; Korten G; Nagel H; Nizze H; Schuff-Werner P Clin Chim Acta; 2000 Jul; 297(1-2):93-102. PubMed ID: 10841912 [TBL] [Abstract][Full Text] [Related]
5. [Microalbumin excretion in the group of patients with asymptomatic hematuria]. Nakamura S; Azuma T Nihon Jinzo Gakkai Shi; 1992 Mar; 34(3):273-7. PubMed ID: 1352833 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase. Hsu WS; Kao JT; Chen JS Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671 [TBL] [Abstract][Full Text] [Related]
7. [Enzymuria and kidney diseases in childhood]. Ehrich JH; Wurster U; Lütge M; Doehring E; Oemar B Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198 [TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of albumin and enzymes in non-insulin-dependent Chinese diabetics. Cheung CK; Yeung VT; Cockram CS; Swaminathan R Clin Nephrol; 1990 Sep; 34(3):125-30. PubMed ID: 1977540 [TBL] [Abstract][Full Text] [Related]
9. Chronic renal tubular effects in relation to urine cadmium levels. Mueller PW; Smith SJ; Steinberg KK; Thun MJ Nephron; 1989; 52(1):45-54. PubMed ID: 2565539 [TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy]. Minakami H Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771 [TBL] [Abstract][Full Text] [Related]
11. Enzyme activities of urinary alanine aminopeptidase (AAP) and N-acetyl-beta-D-glucosaminidase (NAG) in healthy dogs. Reusch C; Vochezer R; Weschta E Zentralbl Veterinarmed A; 1991 Mar; 38(2):90-8. PubMed ID: 1677227 [TBL] [Abstract][Full Text] [Related]
12. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients]. Hirai M; Nakano H; Oba K; Metori S Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372 [TBL] [Abstract][Full Text] [Related]
13. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes. Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570 [TBL] [Abstract][Full Text] [Related]
14. [Neonatal hypoxic-ischemic nephropathy and urinary diagnostic indices: the utility of measuring tubular enzymes (NAG and AAP)]. Bertotti A; De Marchi S; Brovedani P; Gaeta G; Peratoner L; Mangiarotti MA Pediatr Med Chir; 1990; 12(4):347-9. PubMed ID: 1981610 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of urinary N-acetyl-beta-D-glucosaminidase (NAG), alanine-aminopeptidase (AAP) and beta-2-microglobulin (beta 2M) in evaluating nephrotoxicity of gentamicin. Gibey R; Dupond JL; Alber D; Leconte des Floris R; Henry JC Clin Chim Acta; 1981 Oct; 116(1):25-34. PubMed ID: 6172216 [TBL] [Abstract][Full Text] [Related]
16. Study on the relation between renal tubular disorders and glomerular dysfunction in the early phase of insulin-dependent diabetes mellitus in children. Asami T; Nakano T; Sakai K Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):57-63. PubMed ID: 1593797 [TBL] [Abstract][Full Text] [Related]
17. [Urinary excretion of glycine.prolile dipeptidile aminopeptidase, N-acetyl-beta-D-glucosaminidase, alanine aminopeptidase and low molecular protein in patients with renal cell carcinoma]. Kitamura Y; Watanabe M; Komatsubara S; Sakata Y Hinyokika Kiyo; 1990 May; 36(5):535-9. PubMed ID: 1698011 [TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage. Banu N; Hara H; Okamura M; Egusa G; Yamakido M Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760 [TBL] [Abstract][Full Text] [Related]
19. Significance of the measurement of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase activity in evaluating patients with essential hypertension. Kohno M; Kanayama Y; Yasunari K; Kawarabayashi T; Murakawa K; Takeuchi K; Inoue T; Takeda T Clin Exp Hypertens A; 1985; 7(10):1347-60. PubMed ID: 2866856 [TBL] [Abstract][Full Text] [Related]
20. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients. Uslu S; Efe B; Alataş O; Kebapçi N; Colak O; Demirüstü C; Yörük A J Nephrol; 2005; 18(5):559-67. PubMed ID: 16299682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]